drugset / Trial / NCT00439855

Enoxaparin Versus Unfractionated Heparin in PCI

NCT00439855

Phase 4 Completed 2100 enrolled Triemli Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI

Timeline

Start
2003-09
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 0.75 mg/kg Intravenous
Subject Heparin Other / unclassified